Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras

The continued spread of the HIV epidemic underscores the need to interrupt transmission. One attractive strategy is a topical vaginal microbicide. Sexual transmission of herpes simplex virus type 2 (HSV-2) in mice can be inhibited by intravaginal siRNA application. To overcome the challenges of knoc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical investigation 2011-06, Vol.121 (6), p.2401-2412
Hauptverfasser: Wheeler, Lee Adam, Trifonova, Radiana, Vrbanac, Vladimir, Basar, Emre, McKernan, Shannon, Xu, Zhan, Seung, Edward, Deruaz, Maud, Dudek, Tim, Einarsson, Jon Ivar, Yang, Linda, Allen, Todd M, Luster, Andrew D, Tager, Andrew M, Dykxhoorn, Derek M, Lieberman, Judy
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2412
container_issue 6
container_start_page 2401
container_title The Journal of clinical investigation
container_volume 121
creator Wheeler, Lee Adam
Trifonova, Radiana
Vrbanac, Vladimir
Basar, Emre
McKernan, Shannon
Xu, Zhan
Seung, Edward
Deruaz, Maud
Dudek, Tim
Einarsson, Jon Ivar
Yang, Linda
Allen, Todd M
Luster, Andrew D
Tager, Andrew M
Dykxhoorn, Derek M
Lieberman, Judy
description The continued spread of the HIV epidemic underscores the need to interrupt transmission. One attractive strategy is a topical vaginal microbicide. Sexual transmission of herpes simplex virus type 2 (HSV-2) in mice can be inhibited by intravaginal siRNA application. To overcome the challenges of knocking down gene expression in immune cells susceptible to HIV infection, we used chimeric RNAs composed of an aptamer fused to an siRNA for targeted gene knockdown in cells bearing an aptamer-binding receptor. Here, we showed that CD4 aptamer-siRNA chimeras (CD4-AsiCs) specifically suppress gene expression in CD4⁺ T cells and macrophages in vitro, in polarized cervicovaginal tissue explants, and in the female genital tract of humanized mice. CD4-AsiCs do not activate lymphocytes or stimulate innate immunity. CD4-AsiCs that knock down HIV genes and/or CCR5 inhibited HIV infection in vitro and in tissue explants. When applied intravaginally to humanized mice, CD4-AsiCs protected against HIV vaginal transmission. Thus, CD4-AsiCs could be used as the active ingredient of a microbicide to prevent HIV sexual transmission.
doi_str_mv 10.1172/JCI45876
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3104760</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A348997217</galeid><sourcerecordid>A348997217</sourcerecordid><originalsourceid>FETCH-LOGICAL-c668t-5531dc38c8c07549b056c67874127c7d19b4e54baa07e5812e5683b5f2dee9bc3</originalsourceid><addsrcrecordid>eNqNkk9r3DAQxUVpabZpoZ-giBZKe3Aq2ZIlXwrL9k9cQgNpm6uQ5bGtYEtby16SfPpq2SRkYQ9FB6HRbx7Mm4fQa0pOKBXppx-rknEp8idoQTmXiUwz-RQtCElpUohMHqEXIVwRQhnj7Dk6SikXuaRygULpOlvZyXqHfYNPy0s8jdqFwYawrVmHu3nQDhsYN9b4jW6t0z2G63Wv3RSwdvWOsLdQ48EawHOwrsWrLwzr9aQHGJNgL34uselsfOjwEj1rdB_g1d19jP58-_p7dZqcnX8vV8uzxOS5nBLOM1qbTBppiOCsqAjPTS6kYDQVRtS0qBhwVmlNBHBJU-C5zCrepDVAUZnsGH3e6a7naoDagIuj9Wo92kGPN8prq_Z_nO1U6zcqo4SJnESBt3cCo_87Q5jUlZ_HOH5QUqRESkZZhN7toFb3oKxrfNQy0T-jlhmTRSFSKiKVHKBacNGQ3jtobCzv8ScH-HhqiB4fbPi41xCZCa6nVs8hqPLXxf-z55f77PtHbAe6n7rg-3mbmLAPftiBZvQhjNA8GE2J2qZU3ac0om8eL-YBvI9l9g_Xc97e</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>872088414</pqid></control><display><type>article</type><title>Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>Wheeler, Lee Adam ; Trifonova, Radiana ; Vrbanac, Vladimir ; Basar, Emre ; McKernan, Shannon ; Xu, Zhan ; Seung, Edward ; Deruaz, Maud ; Dudek, Tim ; Einarsson, Jon Ivar ; Yang, Linda ; Allen, Todd M ; Luster, Andrew D ; Tager, Andrew M ; Dykxhoorn, Derek M ; Lieberman, Judy</creator><creatorcontrib>Wheeler, Lee Adam ; Trifonova, Radiana ; Vrbanac, Vladimir ; Basar, Emre ; McKernan, Shannon ; Xu, Zhan ; Seung, Edward ; Deruaz, Maud ; Dudek, Tim ; Einarsson, Jon Ivar ; Yang, Linda ; Allen, Todd M ; Luster, Andrew D ; Tager, Andrew M ; Dykxhoorn, Derek M ; Lieberman, Judy</creatorcontrib><description>The continued spread of the HIV epidemic underscores the need to interrupt transmission. One attractive strategy is a topical vaginal microbicide. Sexual transmission of herpes simplex virus type 2 (HSV-2) in mice can be inhibited by intravaginal siRNA application. To overcome the challenges of knocking down gene expression in immune cells susceptible to HIV infection, we used chimeric RNAs composed of an aptamer fused to an siRNA for targeted gene knockdown in cells bearing an aptamer-binding receptor. Here, we showed that CD4 aptamer-siRNA chimeras (CD4-AsiCs) specifically suppress gene expression in CD4⁺ T cells and macrophages in vitro, in polarized cervicovaginal tissue explants, and in the female genital tract of humanized mice. CD4-AsiCs do not activate lymphocytes or stimulate innate immunity. CD4-AsiCs that knock down HIV genes and/or CCR5 inhibited HIV infection in vitro and in tissue explants. When applied intravaginally to humanized mice, CD4-AsiCs protected against HIV vaginal transmission. Thus, CD4-AsiCs could be used as the active ingredient of a microbicide to prevent HIV sexual transmission.</description><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/JCI45876</identifier><identifier>PMID: 21576818</identifier><language>eng</language><publisher>United States: American Society for Clinical Investigation</publisher><subject>Administration, Intravaginal ; Animals ; Anti-infective agents ; Aptamers, Nucleotide - administration &amp; dosage ; Aptamers, Nucleotide - therapeutic use ; Base Sequence ; Biomedical research ; CD4 Antigens - genetics ; CD4 Antigens - metabolism ; CD4-Positive T-Lymphocytes - drug effects ; CD4-Positive T-Lymphocytes - immunology ; Cell Polarity ; Cells, Cultured - drug effects ; Cells, Cultured - metabolism ; Cervix Uteri - drug effects ; Cervix Uteri - virology ; Disease transmission ; Drug Evaluation, Preclinical ; Female ; Flow cytometry ; Gene expression ; Gene Expression Regulation - drug effects ; Gene Knockdown Techniques ; Genes ; Genes, gag ; Genes, vif ; Health aspects ; Herpes viruses ; HIV ; HIV (Viruses) ; HIV Infections - prevention &amp; control ; HIV Infections - transmission ; Human immunodeficiency virus ; Humans ; Infection ; Infections ; Lymphocytes ; Macrophages - drug effects ; Macrophages - immunology ; Macrophages - metabolism ; Medical equipment and supplies industry ; Medical test kit industry ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Molecular Sequence Data ; Organ Culture Techniques ; Prostate ; Receptors, CCR5 - genetics ; RNA, Small Interfering - administration &amp; dosage ; RNA, Small Interfering - therapeutic use ; Species Specificity ; T cells ; Transplantation Chimera - immunology ; Transplantation Chimera - virology ; Vagina ; Vagina - drug effects ; Vagina - virology</subject><ispartof>The Journal of clinical investigation, 2011-06, Vol.121 (6), p.2401-2412</ispartof><rights>COPYRIGHT 2011 American Society for Clinical Investigation</rights><rights>Copyright American Society for Clinical Investigation Jun 2011</rights><rights>Copyright © 2011, American Society for Clinical Investigation 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c668t-5531dc38c8c07549b056c67874127c7d19b4e54baa07e5812e5683b5f2dee9bc3</citedby><cites>FETCH-LOGICAL-c668t-5531dc38c8c07549b056c67874127c7d19b4e54baa07e5812e5683b5f2dee9bc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104760/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104760/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21576818$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wheeler, Lee Adam</creatorcontrib><creatorcontrib>Trifonova, Radiana</creatorcontrib><creatorcontrib>Vrbanac, Vladimir</creatorcontrib><creatorcontrib>Basar, Emre</creatorcontrib><creatorcontrib>McKernan, Shannon</creatorcontrib><creatorcontrib>Xu, Zhan</creatorcontrib><creatorcontrib>Seung, Edward</creatorcontrib><creatorcontrib>Deruaz, Maud</creatorcontrib><creatorcontrib>Dudek, Tim</creatorcontrib><creatorcontrib>Einarsson, Jon Ivar</creatorcontrib><creatorcontrib>Yang, Linda</creatorcontrib><creatorcontrib>Allen, Todd M</creatorcontrib><creatorcontrib>Luster, Andrew D</creatorcontrib><creatorcontrib>Tager, Andrew M</creatorcontrib><creatorcontrib>Dykxhoorn, Derek M</creatorcontrib><creatorcontrib>Lieberman, Judy</creatorcontrib><title>Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras</title><title>The Journal of clinical investigation</title><addtitle>J Clin Invest</addtitle><description>The continued spread of the HIV epidemic underscores the need to interrupt transmission. One attractive strategy is a topical vaginal microbicide. Sexual transmission of herpes simplex virus type 2 (HSV-2) in mice can be inhibited by intravaginal siRNA application. To overcome the challenges of knocking down gene expression in immune cells susceptible to HIV infection, we used chimeric RNAs composed of an aptamer fused to an siRNA for targeted gene knockdown in cells bearing an aptamer-binding receptor. Here, we showed that CD4 aptamer-siRNA chimeras (CD4-AsiCs) specifically suppress gene expression in CD4⁺ T cells and macrophages in vitro, in polarized cervicovaginal tissue explants, and in the female genital tract of humanized mice. CD4-AsiCs do not activate lymphocytes or stimulate innate immunity. CD4-AsiCs that knock down HIV genes and/or CCR5 inhibited HIV infection in vitro and in tissue explants. When applied intravaginally to humanized mice, CD4-AsiCs protected against HIV vaginal transmission. Thus, CD4-AsiCs could be used as the active ingredient of a microbicide to prevent HIV sexual transmission.</description><subject>Administration, Intravaginal</subject><subject>Animals</subject><subject>Anti-infective agents</subject><subject>Aptamers, Nucleotide - administration &amp; dosage</subject><subject>Aptamers, Nucleotide - therapeutic use</subject><subject>Base Sequence</subject><subject>Biomedical research</subject><subject>CD4 Antigens - genetics</subject><subject>CD4 Antigens - metabolism</subject><subject>CD4-Positive T-Lymphocytes - drug effects</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>Cell Polarity</subject><subject>Cells, Cultured - drug effects</subject><subject>Cells, Cultured - metabolism</subject><subject>Cervix Uteri - drug effects</subject><subject>Cervix Uteri - virology</subject><subject>Disease transmission</subject><subject>Drug Evaluation, Preclinical</subject><subject>Female</subject><subject>Flow cytometry</subject><subject>Gene expression</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Gene Knockdown Techniques</subject><subject>Genes</subject><subject>Genes, gag</subject><subject>Genes, vif</subject><subject>Health aspects</subject><subject>Herpes viruses</subject><subject>HIV</subject><subject>HIV (Viruses)</subject><subject>HIV Infections - prevention &amp; control</subject><subject>HIV Infections - transmission</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infection</subject><subject>Infections</subject><subject>Lymphocytes</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - immunology</subject><subject>Macrophages - metabolism</subject><subject>Medical equipment and supplies industry</subject><subject>Medical test kit industry</subject><subject>Mice</subject><subject>Mice, Inbred NOD</subject><subject>Mice, SCID</subject><subject>Molecular Sequence Data</subject><subject>Organ Culture Techniques</subject><subject>Prostate</subject><subject>Receptors, CCR5 - genetics</subject><subject>RNA, Small Interfering - administration &amp; dosage</subject><subject>RNA, Small Interfering - therapeutic use</subject><subject>Species Specificity</subject><subject>T cells</subject><subject>Transplantation Chimera - immunology</subject><subject>Transplantation Chimera - virology</subject><subject>Vagina</subject><subject>Vagina - drug effects</subject><subject>Vagina - virology</subject><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkk9r3DAQxUVpabZpoZ-giBZKe3Aq2ZIlXwrL9k9cQgNpm6uQ5bGtYEtby16SfPpq2SRkYQ9FB6HRbx7Mm4fQa0pOKBXppx-rknEp8idoQTmXiUwz-RQtCElpUohMHqEXIVwRQhnj7Dk6SikXuaRygULpOlvZyXqHfYNPy0s8jdqFwYawrVmHu3nQDhsYN9b4jW6t0z2G63Wv3RSwdvWOsLdQ48EawHOwrsWrLwzr9aQHGJNgL34uselsfOjwEj1rdB_g1d19jP58-_p7dZqcnX8vV8uzxOS5nBLOM1qbTBppiOCsqAjPTS6kYDQVRtS0qBhwVmlNBHBJU-C5zCrepDVAUZnsGH3e6a7naoDagIuj9Wo92kGPN8prq_Z_nO1U6zcqo4SJnESBt3cCo_87Q5jUlZ_HOH5QUqRESkZZhN7toFb3oKxrfNQy0T-jlhmTRSFSKiKVHKBacNGQ3jtobCzv8ScH-HhqiB4fbPi41xCZCa6nVs8hqPLXxf-z55f77PtHbAe6n7rg-3mbmLAPftiBZvQhjNA8GE2J2qZU3ac0om8eL-YBvI9l9g_Xc97e</recordid><startdate>20110601</startdate><enddate>20110601</enddate><creator>Wheeler, Lee Adam</creator><creator>Trifonova, Radiana</creator><creator>Vrbanac, Vladimir</creator><creator>Basar, Emre</creator><creator>McKernan, Shannon</creator><creator>Xu, Zhan</creator><creator>Seung, Edward</creator><creator>Deruaz, Maud</creator><creator>Dudek, Tim</creator><creator>Einarsson, Jon Ivar</creator><creator>Yang, Linda</creator><creator>Allen, Todd M</creator><creator>Luster, Andrew D</creator><creator>Tager, Andrew M</creator><creator>Dykxhoorn, Derek M</creator><creator>Lieberman, Judy</creator><general>American Society for Clinical Investigation</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>S0X</scope><scope>5PM</scope></search><sort><creationdate>20110601</creationdate><title>Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras</title><author>Wheeler, Lee Adam ; Trifonova, Radiana ; Vrbanac, Vladimir ; Basar, Emre ; McKernan, Shannon ; Xu, Zhan ; Seung, Edward ; Deruaz, Maud ; Dudek, Tim ; Einarsson, Jon Ivar ; Yang, Linda ; Allen, Todd M ; Luster, Andrew D ; Tager, Andrew M ; Dykxhoorn, Derek M ; Lieberman, Judy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c668t-5531dc38c8c07549b056c67874127c7d19b4e54baa07e5812e5683b5f2dee9bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Administration, Intravaginal</topic><topic>Animals</topic><topic>Anti-infective agents</topic><topic>Aptamers, Nucleotide - administration &amp; dosage</topic><topic>Aptamers, Nucleotide - therapeutic use</topic><topic>Base Sequence</topic><topic>Biomedical research</topic><topic>CD4 Antigens - genetics</topic><topic>CD4 Antigens - metabolism</topic><topic>CD4-Positive T-Lymphocytes - drug effects</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>Cell Polarity</topic><topic>Cells, Cultured - drug effects</topic><topic>Cells, Cultured - metabolism</topic><topic>Cervix Uteri - drug effects</topic><topic>Cervix Uteri - virology</topic><topic>Disease transmission</topic><topic>Drug Evaluation, Preclinical</topic><topic>Female</topic><topic>Flow cytometry</topic><topic>Gene expression</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Gene Knockdown Techniques</topic><topic>Genes</topic><topic>Genes, gag</topic><topic>Genes, vif</topic><topic>Health aspects</topic><topic>Herpes viruses</topic><topic>HIV</topic><topic>HIV (Viruses)</topic><topic>HIV Infections - prevention &amp; control</topic><topic>HIV Infections - transmission</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infection</topic><topic>Infections</topic><topic>Lymphocytes</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - immunology</topic><topic>Macrophages - metabolism</topic><topic>Medical equipment and supplies industry</topic><topic>Medical test kit industry</topic><topic>Mice</topic><topic>Mice, Inbred NOD</topic><topic>Mice, SCID</topic><topic>Molecular Sequence Data</topic><topic>Organ Culture Techniques</topic><topic>Prostate</topic><topic>Receptors, CCR5 - genetics</topic><topic>RNA, Small Interfering - administration &amp; dosage</topic><topic>RNA, Small Interfering - therapeutic use</topic><topic>Species Specificity</topic><topic>T cells</topic><topic>Transplantation Chimera - immunology</topic><topic>Transplantation Chimera - virology</topic><topic>Vagina</topic><topic>Vagina - drug effects</topic><topic>Vagina - virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wheeler, Lee Adam</creatorcontrib><creatorcontrib>Trifonova, Radiana</creatorcontrib><creatorcontrib>Vrbanac, Vladimir</creatorcontrib><creatorcontrib>Basar, Emre</creatorcontrib><creatorcontrib>McKernan, Shannon</creatorcontrib><creatorcontrib>Xu, Zhan</creatorcontrib><creatorcontrib>Seung, Edward</creatorcontrib><creatorcontrib>Deruaz, Maud</creatorcontrib><creatorcontrib>Dudek, Tim</creatorcontrib><creatorcontrib>Einarsson, Jon Ivar</creatorcontrib><creatorcontrib>Yang, Linda</creatorcontrib><creatorcontrib>Allen, Todd M</creatorcontrib><creatorcontrib>Luster, Andrew D</creatorcontrib><creatorcontrib>Tager, Andrew M</creatorcontrib><creatorcontrib>Dykxhoorn, Derek M</creatorcontrib><creatorcontrib>Lieberman, Judy</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SIRS Editorial</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wheeler, Lee Adam</au><au>Trifonova, Radiana</au><au>Vrbanac, Vladimir</au><au>Basar, Emre</au><au>McKernan, Shannon</au><au>Xu, Zhan</au><au>Seung, Edward</au><au>Deruaz, Maud</au><au>Dudek, Tim</au><au>Einarsson, Jon Ivar</au><au>Yang, Linda</au><au>Allen, Todd M</au><au>Luster, Andrew D</au><au>Tager, Andrew M</au><au>Dykxhoorn, Derek M</au><au>Lieberman, Judy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras</atitle><jtitle>The Journal of clinical investigation</jtitle><addtitle>J Clin Invest</addtitle><date>2011-06-01</date><risdate>2011</risdate><volume>121</volume><issue>6</issue><spage>2401</spage><epage>2412</epage><pages>2401-2412</pages><issn>0021-9738</issn><eissn>1558-8238</eissn><abstract>The continued spread of the HIV epidemic underscores the need to interrupt transmission. One attractive strategy is a topical vaginal microbicide. Sexual transmission of herpes simplex virus type 2 (HSV-2) in mice can be inhibited by intravaginal siRNA application. To overcome the challenges of knocking down gene expression in immune cells susceptible to HIV infection, we used chimeric RNAs composed of an aptamer fused to an siRNA for targeted gene knockdown in cells bearing an aptamer-binding receptor. Here, we showed that CD4 aptamer-siRNA chimeras (CD4-AsiCs) specifically suppress gene expression in CD4⁺ T cells and macrophages in vitro, in polarized cervicovaginal tissue explants, and in the female genital tract of humanized mice. CD4-AsiCs do not activate lymphocytes or stimulate innate immunity. CD4-AsiCs that knock down HIV genes and/or CCR5 inhibited HIV infection in vitro and in tissue explants. When applied intravaginally to humanized mice, CD4-AsiCs protected against HIV vaginal transmission. Thus, CD4-AsiCs could be used as the active ingredient of a microbicide to prevent HIV sexual transmission.</abstract><cop>United States</cop><pub>American Society for Clinical Investigation</pub><pmid>21576818</pmid><doi>10.1172/JCI45876</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9738
ispartof The Journal of clinical investigation, 2011-06, Vol.121 (6), p.2401-2412
issn 0021-9738
1558-8238
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3104760
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection; Journals@Ovid Complete
subjects Administration, Intravaginal
Animals
Anti-infective agents
Aptamers, Nucleotide - administration & dosage
Aptamers, Nucleotide - therapeutic use
Base Sequence
Biomedical research
CD4 Antigens - genetics
CD4 Antigens - metabolism
CD4-Positive T-Lymphocytes - drug effects
CD4-Positive T-Lymphocytes - immunology
Cell Polarity
Cells, Cultured - drug effects
Cells, Cultured - metabolism
Cervix Uteri - drug effects
Cervix Uteri - virology
Disease transmission
Drug Evaluation, Preclinical
Female
Flow cytometry
Gene expression
Gene Expression Regulation - drug effects
Gene Knockdown Techniques
Genes
Genes, gag
Genes, vif
Health aspects
Herpes viruses
HIV
HIV (Viruses)
HIV Infections - prevention & control
HIV Infections - transmission
Human immunodeficiency virus
Humans
Infection
Infections
Lymphocytes
Macrophages - drug effects
Macrophages - immunology
Macrophages - metabolism
Medical equipment and supplies industry
Medical test kit industry
Mice
Mice, Inbred NOD
Mice, SCID
Molecular Sequence Data
Organ Culture Techniques
Prostate
Receptors, CCR5 - genetics
RNA, Small Interfering - administration & dosage
RNA, Small Interfering - therapeutic use
Species Specificity
T cells
Transplantation Chimera - immunology
Transplantation Chimera - virology
Vagina
Vagina - drug effects
Vagina - virology
title Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T10%3A12%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20HIV%20transmission%20in%20human%20cervicovaginal%20explants%20and%20humanized%20mice%20using%20CD4%20aptamer-siRNA%20chimeras&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Wheeler,%20Lee%20Adam&rft.date=2011-06-01&rft.volume=121&rft.issue=6&rft.spage=2401&rft.epage=2412&rft.pages=2401-2412&rft.issn=0021-9738&rft.eissn=1558-8238&rft_id=info:doi/10.1172/JCI45876&rft_dat=%3Cgale_pubme%3EA348997217%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=872088414&rft_id=info:pmid/21576818&rft_galeid=A348997217&rfr_iscdi=true